Now showing items 1-1 of 1

    • Dosimetry-based treatment for Graves' disease. 

      Hyer, SL; Pratt, B; Gray, M; Chittenden, S; Du, Y; Harmer, CL; Flux, GD (2018-06)
      OBJECTIVE: The aim of this retrospective study was to assess the long-term outcome of a personalized dosimetry approach in Graves' disease aiming to render patients euthyroid from a planned thyroid absorbed dose of 60 Gy. ...